Global Short-Acting Insulin Market is Expected to Cross ~USD 9 Billion by 2030 | DelveInsight

The growing incidence of diabetes, driven by sedentary lifestyles and poor dietary habits, has heightened the need for insulin therapy to effectively control blood glucose levels. Additionally, increased awareness and diagnosis of diabetes worldwide have motivated more individuals to…